Alnylam's slump deepens; Q2 earnings roundup; and more

Welcome to another edition of Endpoints Weekly, and happy August! The summer is speeding right along, and we’ve got the latest from biopharma’s earnings-palooza this week. Let’s dive into the ...

Raccontata daendpoints.news